Verrica Pharmaceuticals company info

What does Verrica Pharmaceuticals do?
Verrica Pharmaceuticals (NASDAQ:VRCA) is a dermatology-focused company dedicated to developing and commercializing innovative treatments for skin diseases. Their flagship project involves a topical therapy designed to address molluscum contagiosum, a viral infection causing skin lesions. With this effort, Verrica aims to meet the pressing needs of patients who suffer from this and other underserved medical conditions. Their commitment extends beyond molluscum contagiosum, as they leverage their proprietary technology to explore treatments for additional dermatological issues. The company's ultimate objective is to improve the lives of those afflicted by challenging skin diseases through the power of science and innovation.
Verrica Pharmaceuticals company media
Company Snapshot

Is Verrica Pharmaceuticals a public or private company?

key
Ownership
Public

How many people does Verrica Pharmaceuticals employ?

people
Employees
100

What sector is Verrica Pharmaceuticals in?

pie chart
Sector
Health Care

Where is the head office for Verrica Pharmaceuticals?

location pin
Head Office
West Chester, United States

What year was Verrica Pharmaceuticals founded?

founded flag
Year Founded
2013
What does Verrica Pharmaceuticals specialise in?
/Dermatology Therapeutics /Skin Disease Treatments /VP-102 Product /Non-Invasive Solutions /VP-103 Project /Clinical Trials

What are the products and/or services of Verrica Pharmaceuticals?

Overview of Verrica Pharmaceuticals offerings
VP-102 for the treatment of molluscum contagiosum, a highly contagious skin infection.
VP-103 for plantar warts, leveraging the company’s proprietary cantharidin formulation.
VP-102 for common warts, expanding the applications of their lead compound.
Research on cantharidin-based formulations for potential use in other dermatological conditions.
Partnership initiatives for the commercialization and distribution of their dermatological treatments.
Development of a pipeline focusing on unmet needs in pediatric dermatology.

Who is in the executive team of Verrica Pharmaceuticals?

Verrica Pharmaceuticals leadership team
  • Mr. Ted  White
    Mr. Ted White
    President, CEO & Director
  • Mr. Joe  Bonaccorso
    Mr. Joe Bonaccorso
    Chief Commercial Officer
  • Dr. Gary  Goldenberg M.D.
    Dr. Gary Goldenberg M.D.
    Chief Medical Officer
  • Mr. P. Terence  Kohler
    Mr. P. Terence Kohler
    Chief Financial Officer
  • Mr. Christopher G. Hayes
    Mr. Christopher G. Hayes
    Chief Legal Officer, Secretary, Chief Compliance Officer & General Counsel
  • Mr. Eugene  Scavola
    Mr. Eugene Scavola
    Executive Vice President of Technical Operations
  • Dr. Bradley J. Catalone MBA, Ph.D.
    Dr. Bradley J. Catalone MBA, Ph.D.
    Head of Drug Development